Peptide microarrays coupled to machine learning reveal individual epitopes from human antibody responses with neutralizing capabilities against SARS-CoV-2

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autoren

  • Sven Kevin Hotop
  • Susanne Reimering
  • Aditya Shekhar
  • Ehsaneddin Asgari
  • Ulrike Beutling
  • Christine Dahlke
  • Anahita Fathi
  • Fawad Khan
  • Marc Lütgehetmann
  • Rico Ballmann
  • Andreas Gerstner
  • Werner Tegge
  • Luka Cicin-Sain
  • Ursula Bilitewski
  • Alice C. McHardy
  • Mark Brönstrup

Externe Organisationen

  • Helmholtz-Zentrum für Infektionsforschung GmbH (HZI)
  • Technische Universität Braunschweig
  • Universität Hamburg
  • Bernhard-Nocht-Institut für Tropenmedizin (BNITM)
  • Deutsches Zentrum für Infektionsforschung (DZIF)
  • Städtisches Klinikum Braunschweig
Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Seiten (von - bis)1037-1048
Seitenumfang12
FachzeitschriftEmerging Microbes and Infections
Jahrgang11
Ausgabenummer1
PublikationsstatusVeröffentlicht - 2022

Abstract

The coronavirus SARS-CoV-2 is the causative agent for the disease COVID-19. To capture the IgA, IgG, and IgM antibody response of patients infected with SARS-CoV-2 at individual epitope resolution, we constructed planar microarrays of 648 overlapping peptides that cover the four major structural proteins S(pike), N(ucleocapsid), M(embrane), and E(nvelope). The arrays were incubated with sera of 67 SARS-CoV-2 positive and 22 negative control samples. Specific responses to SARS-CoV-2 were detectable, and nine peptides were associated with a more severe course of the disease. A random forest model disclosed that antibody binding to 21 peptides, mostly localized in the S protein, was associated with higher neutralization values in cellular anti-SARS-CoV-2 assays. For antibodies addressing the N-terminus of M, or peptides close to the fusion region of S, protective effects were proven by antibody depletion and neutralization assays. The study pinpoints unusual viral binding epitopes that might be suited as vaccine candidates.

ASJC Scopus Sachgebiete

Ziele für nachhaltige Entwicklung

Zitieren

Peptide microarrays coupled to machine learning reveal individual epitopes from human antibody responses with neutralizing capabilities against SARS-CoV-2. / Hotop, Sven Kevin; Reimering, Susanne; Shekhar, Aditya et al.
in: Emerging Microbes and Infections, Jahrgang 11, Nr. 1, 2022, S. 1037-1048.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Hotop, SK, Reimering, S, Shekhar, A, Asgari, E, Beutling, U, Dahlke, C, Fathi, A, Khan, F, Lütgehetmann, M, Ballmann, R, Gerstner, A, Tegge, W, Cicin-Sain, L, Bilitewski, U, McHardy, AC & Brönstrup, M 2022, 'Peptide microarrays coupled to machine learning reveal individual epitopes from human antibody responses with neutralizing capabilities against SARS-CoV-2', Emerging Microbes and Infections, Jg. 11, Nr. 1, S. 1037-1048. https://doi.org/10.1080/22221751.2022.2057874
Hotop, S. K., Reimering, S., Shekhar, A., Asgari, E., Beutling, U., Dahlke, C., Fathi, A., Khan, F., Lütgehetmann, M., Ballmann, R., Gerstner, A., Tegge, W., Cicin-Sain, L., Bilitewski, U., McHardy, A. C., & Brönstrup, M. (2022). Peptide microarrays coupled to machine learning reveal individual epitopes from human antibody responses with neutralizing capabilities against SARS-CoV-2. Emerging Microbes and Infections, 11(1), 1037-1048. https://doi.org/10.1080/22221751.2022.2057874
Hotop SK, Reimering S, Shekhar A, Asgari E, Beutling U, Dahlke C et al. Peptide microarrays coupled to machine learning reveal individual epitopes from human antibody responses with neutralizing capabilities against SARS-CoV-2. Emerging Microbes and Infections. 2022;11(1):1037-1048. doi: 10.1080/22221751.2022.2057874
Download
@article{1d6dfc83be544a7f988f21e482469744,
title = "Peptide microarrays coupled to machine learning reveal individual epitopes from human antibody responses with neutralizing capabilities against SARS-CoV-2",
abstract = "The coronavirus SARS-CoV-2 is the causative agent for the disease COVID-19. To capture the IgA, IgG, and IgM antibody response of patients infected with SARS-CoV-2 at individual epitope resolution, we constructed planar microarrays of 648 overlapping peptides that cover the four major structural proteins S(pike), N(ucleocapsid), M(embrane), and E(nvelope). The arrays were incubated with sera of 67 SARS-CoV-2 positive and 22 negative control samples. Specific responses to SARS-CoV-2 were detectable, and nine peptides were associated with a more severe course of the disease. A random forest model disclosed that antibody binding to 21 peptides, mostly localized in the S protein, was associated with higher neutralization values in cellular anti-SARS-CoV-2 assays. For antibodies addressing the N-terminus of M, or peptides close to the fusion region of S, protective effects were proven by antibody depletion and neutralization assays. The study pinpoints unusual viral binding epitopes that might be suited as vaccine candidates.",
keywords = "COVID-19, immunoassays, machine learning, neutralizing antibodies, peptide arrays, SARS CoV-2, serology",
author = "Hotop, {Sven Kevin} and Susanne Reimering and Aditya Shekhar and Ehsaneddin Asgari and Ulrike Beutling and Christine Dahlke and Anahita Fathi and Fawad Khan and Marc L{\"u}tgehetmann and Rico Ballmann and Andreas Gerstner and Werner Tegge and Luka Cicin-Sain and Ursula Bilitewski and McHardy, {Alice C.} and Mark Br{\"o}nstrup",
note = "Funding Information: The work was funded by a grant from the Ministry of Science and Culture of Lower Saxony in Germany (project 14-76103-184 Corona 13/20) and by the COVID-19 Research Network of the State of Lower Saxony (COFONI) (14-76403-184). The authors thank Michael Hust for providing the SH2029-G6 monoclonal antibody for assay validation. We also thank the HZI peptide facility, in particular Brigitte Kornak, for its peptide synthesis support. SKH, UBE, RB and WT manufactured chips, performed chip experiments and analyzed the data; CD, AF, ML and AG characterized and provided the serum samples; AS, FK performed SARS-CoV-2 neutralization experiments, UBI, LC conceived and supervised SARS-CoV-2 neutralization experiments, SR, EA and AM analyzed the data. MB conceived the study, analyzed the data and wrote the manuscript. ",
year = "2022",
doi = "10.1080/22221751.2022.2057874",
language = "English",
volume = "11",
pages = "1037--1048",
journal = "Emerging Microbes and Infections",
issn = "2222-1751",
publisher = "Nature Publishing Group",
number = "1",

}

Download

TY - JOUR

T1 - Peptide microarrays coupled to machine learning reveal individual epitopes from human antibody responses with neutralizing capabilities against SARS-CoV-2

AU - Hotop, Sven Kevin

AU - Reimering, Susanne

AU - Shekhar, Aditya

AU - Asgari, Ehsaneddin

AU - Beutling, Ulrike

AU - Dahlke, Christine

AU - Fathi, Anahita

AU - Khan, Fawad

AU - Lütgehetmann, Marc

AU - Ballmann, Rico

AU - Gerstner, Andreas

AU - Tegge, Werner

AU - Cicin-Sain, Luka

AU - Bilitewski, Ursula

AU - McHardy, Alice C.

AU - Brönstrup, Mark

N1 - Funding Information: The work was funded by a grant from the Ministry of Science and Culture of Lower Saxony in Germany (project 14-76103-184 Corona 13/20) and by the COVID-19 Research Network of the State of Lower Saxony (COFONI) (14-76403-184). The authors thank Michael Hust for providing the SH2029-G6 monoclonal antibody for assay validation. We also thank the HZI peptide facility, in particular Brigitte Kornak, for its peptide synthesis support. SKH, UBE, RB and WT manufactured chips, performed chip experiments and analyzed the data; CD, AF, ML and AG characterized and provided the serum samples; AS, FK performed SARS-CoV-2 neutralization experiments, UBI, LC conceived and supervised SARS-CoV-2 neutralization experiments, SR, EA and AM analyzed the data. MB conceived the study, analyzed the data and wrote the manuscript.

PY - 2022

Y1 - 2022

N2 - The coronavirus SARS-CoV-2 is the causative agent for the disease COVID-19. To capture the IgA, IgG, and IgM antibody response of patients infected with SARS-CoV-2 at individual epitope resolution, we constructed planar microarrays of 648 overlapping peptides that cover the four major structural proteins S(pike), N(ucleocapsid), M(embrane), and E(nvelope). The arrays were incubated with sera of 67 SARS-CoV-2 positive and 22 negative control samples. Specific responses to SARS-CoV-2 were detectable, and nine peptides were associated with a more severe course of the disease. A random forest model disclosed that antibody binding to 21 peptides, mostly localized in the S protein, was associated with higher neutralization values in cellular anti-SARS-CoV-2 assays. For antibodies addressing the N-terminus of M, or peptides close to the fusion region of S, protective effects were proven by antibody depletion and neutralization assays. The study pinpoints unusual viral binding epitopes that might be suited as vaccine candidates.

AB - The coronavirus SARS-CoV-2 is the causative agent for the disease COVID-19. To capture the IgA, IgG, and IgM antibody response of patients infected with SARS-CoV-2 at individual epitope resolution, we constructed planar microarrays of 648 overlapping peptides that cover the four major structural proteins S(pike), N(ucleocapsid), M(embrane), and E(nvelope). The arrays were incubated with sera of 67 SARS-CoV-2 positive and 22 negative control samples. Specific responses to SARS-CoV-2 were detectable, and nine peptides were associated with a more severe course of the disease. A random forest model disclosed that antibody binding to 21 peptides, mostly localized in the S protein, was associated with higher neutralization values in cellular anti-SARS-CoV-2 assays. For antibodies addressing the N-terminus of M, or peptides close to the fusion region of S, protective effects were proven by antibody depletion and neutralization assays. The study pinpoints unusual viral binding epitopes that might be suited as vaccine candidates.

KW - COVID-19

KW - immunoassays

KW - machine learning

KW - neutralizing antibodies

KW - peptide arrays

KW - SARS CoV-2

KW - serology

UR - http://www.scopus.com/inward/record.url?scp=85128411633&partnerID=8YFLogxK

U2 - 10.1080/22221751.2022.2057874

DO - 10.1080/22221751.2022.2057874

M3 - Article

C2 - 35320064

AN - SCOPUS:85128411633

VL - 11

SP - 1037

EP - 1048

JO - Emerging Microbes and Infections

JF - Emerging Microbes and Infections

SN - 2222-1751

IS - 1

ER -